MARYGRACE JOHNSON: Open Payments
NPI 1174066799 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,780 in 189 payments from 18 companies in 2025. Trend: 2023 $3,162 · 2024 $3,522 · 2025 $3,780
Food & beverage: $3,780
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 34 | $692 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $615 |
| Aimmune Therapeutics, Inc. | 35 | $517 |
| ABBVIE INC. | 32 | $495 |
| Madrigal Pharmaceuticals | 12 | $372 |
| QOL Medical, LLC | 6 | $219 |
| Ipsen Biopharmaceuticals, Inc | 12 | $146 |
| Phathom Pharmaceuticals, Inc. | 10 | $134 |
| Regeneron Healthcare Solutions, Inc. | 5 | $117 |
| Janssen Scientific Affairs, LLC | 1 | $94 |
Products named: TREMFYA, ZENPEP, REZDIFFRA, ENTYVIO, Sucraid, RINVOQ, GATTEX, CREON.
Industry payments across TX — which companies pay providers there.
